Kristine Specht Burk, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Reimbursement, Incentive | 3 | 2022 | 542 | 0.820 |
Why?
|
Nipples | 1 | 2020 | 229 | 0.630 |
Why?
|
Breast Diseases | 1 | 2020 | 442 | 0.580 |
Why?
|
Neoplasms, Cystic, Mucinous, and Serous | 1 | 2018 | 194 | 0.520 |
Why?
|
Cholangiopancreatography, Magnetic Resonance | 1 | 2015 | 100 | 0.500 |
Why?
|
Magnetic Resonance Imaging | 15 | 2024 | 36430 | 0.440 |
Why?
|
Osteosarcoma | 1 | 2019 | 896 | 0.430 |
Why?
|
Mammography | 2 | 2020 | 2429 | 0.410 |
Why?
|
Calcinosis | 1 | 2020 | 1469 | 0.390 |
Why?
|
Pancreatic Neoplasms | 3 | 2018 | 5363 | 0.390 |
Why?
|
Adnexal Diseases | 2 | 2023 | 105 | 0.380 |
Why?
|
Radiology | 5 | 2023 | 2113 | 0.370 |
Why?
|
Prostatic Neoplasms | 4 | 2024 | 11116 | 0.310 |
Why?
|
Radiology Information Systems | 2 | 2023 | 529 | 0.300 |
Why?
|
Preoperative Care | 1 | 2015 | 2242 | 0.270 |
Why?
|
Tissue Donors | 1 | 2015 | 2331 | 0.260 |
Why?
|
Diagnostic Imaging | 2 | 2023 | 3531 | 0.240 |
Why?
|
Liver Transplantation | 1 | 2015 | 2333 | 0.230 |
Why?
|
Krukenberg Tumor | 1 | 2021 | 12 | 0.200 |
Why?
|
Breast Neoplasms | 5 | 2019 | 21009 | 0.190 |
Why?
|
Prostate-Specific Antigen | 4 | 2024 | 2469 | 0.190 |
Why?
|
Pancreas | 2 | 2018 | 1689 | 0.180 |
Why?
|
Leiomyosarcoma | 1 | 2024 | 422 | 0.170 |
Why?
|
Tomography, X-Ray Computed | 5 | 2023 | 20555 | 0.170 |
Why?
|
Leiomyoma | 1 | 2024 | 636 | 0.160 |
Why?
|
Strongylida Infections | 1 | 2018 | 48 | 0.160 |
Why?
|
Retrospective Studies | 17 | 2024 | 80575 | 0.150 |
Why?
|
Prostate | 2 | 2024 | 1770 | 0.150 |
Why?
|
Radiology, Interventional | 2 | 2023 | 476 | 0.150 |
Why?
|
Biopsy | 3 | 2024 | 6768 | 0.140 |
Why?
|
Ultrasonography, Mammary | 1 | 2019 | 239 | 0.140 |
Why?
|
Image Enhancement | 2 | 2019 | 2884 | 0.140 |
Why?
|
Clinical Coding | 1 | 2018 | 181 | 0.130 |
Why?
|
Endometriosis | 1 | 2024 | 869 | 0.130 |
Why?
|
Abdomen | 1 | 2022 | 1128 | 0.130 |
Why?
|
Peer Group | 1 | 2021 | 692 | 0.130 |
Why?
|
Ovarian Neoplasms | 2 | 2023 | 4877 | 0.120 |
Why?
|
Uterine Neoplasms | 1 | 2024 | 1420 | 0.120 |
Why?
|
Doxorubicin | 1 | 2019 | 2215 | 0.100 |
Why?
|
Humans | 29 | 2024 | 761326 | 0.100 |
Why?
|
Ultrasonography, Interventional | 1 | 2020 | 1495 | 0.100 |
Why?
|
Abdominal Pain | 1 | 2018 | 1071 | 0.100 |
Why?
|
Societies, Medical | 1 | 2024 | 3905 | 0.100 |
Why?
|
Uterine Cervical Neoplasms | 1 | 2024 | 2019 | 0.100 |
Why?
|
Neuroendocrine Tumors | 1 | 2017 | 642 | 0.090 |
Why?
|
Radiography | 4 | 2023 | 6966 | 0.090 |
Why?
|
Mastectomy | 1 | 2019 | 1822 | 0.090 |
Why?
|
Chemotherapy, Adjuvant | 1 | 2019 | 3512 | 0.090 |
Why?
|
Radiography, Interventional | 1 | 2018 | 1121 | 0.090 |
Why?
|
Colon | 1 | 2018 | 1792 | 0.090 |
Why?
|
Checklist | 1 | 2017 | 828 | 0.090 |
Why?
|
Contrast Media | 3 | 2019 | 5310 | 0.080 |
Why?
|
Mass Screening | 3 | 2019 | 5428 | 0.080 |
Why?
|
Artificial Intelligence | 1 | 2023 | 2578 | 0.080 |
Why?
|
Early Detection of Cancer | 2 | 2019 | 3200 | 0.070 |
Why?
|
Ultrasonography | 3 | 2024 | 5970 | 0.060 |
Why?
|
Female | 15 | 2024 | 392485 | 0.060 |
Why?
|
Patient Satisfaction | 1 | 2018 | 3460 | 0.060 |
Why?
|
Clinical Competence | 1 | 2021 | 4793 | 0.060 |
Why?
|
Neoplasm Invasiveness | 2 | 2024 | 3588 | 0.060 |
Why?
|
Internship and Residency | 1 | 2023 | 5877 | 0.050 |
Why?
|
Imaging, Three-Dimensional | 1 | 2015 | 4063 | 0.050 |
Why?
|
Diagnosis, Differential | 3 | 2024 | 12972 | 0.050 |
Why?
|
Aged | 7 | 2024 | 169179 | 0.050 |
Why?
|
Breast | 2 | 2019 | 1966 | 0.040 |
Why?
|
Algorithms | 1 | 2020 | 14025 | 0.040 |
Why?
|
Liver | 1 | 2015 | 7531 | 0.040 |
Why?
|
Electronic Health Records | 1 | 2017 | 4812 | 0.040 |
Why?
|
Image Interpretation, Computer-Assisted | 2 | 2024 | 3356 | 0.040 |
Why?
|
Middle Aged | 9 | 2024 | 220774 | 0.040 |
Why?
|
Parasitic Diseases | 1 | 2018 | 76 | 0.040 |
Why?
|
Male | 7 | 2024 | 360621 | 0.040 |
Why?
|
Antineoplastic Agents | 1 | 2019 | 13635 | 0.030 |
Why?
|
Radiography, Abdominal | 1 | 2018 | 534 | 0.030 |
Why?
|
Predictive Value of Tests | 2 | 2024 | 15262 | 0.030 |
Why?
|
Risk Factors | 4 | 2024 | 74152 | 0.030 |
Why?
|
Natural Language Processing | 1 | 2023 | 1162 | 0.030 |
Why?
|
Eosinophilia | 1 | 2018 | 560 | 0.030 |
Why?
|
Language | 1 | 2023 | 1539 | 0.030 |
Why?
|
Diagnostic Errors | 1 | 2021 | 1265 | 0.030 |
Why?
|
Carcinoma in Situ | 1 | 2019 | 791 | 0.030 |
Why?
|
Evidence-Based Medicine | 1 | 2024 | 3687 | 0.020 |
Why?
|
Program Development | 1 | 2017 | 1298 | 0.020 |
Why?
|
User-Computer Interface | 1 | 2017 | 1399 | 0.020 |
Why?
|
Radiographic Image Interpretation, Computer-Assisted | 1 | 2017 | 1222 | 0.020 |
Why?
|
Colonoscopy | 1 | 2018 | 1394 | 0.020 |
Why?
|
Risk Assessment | 2 | 2024 | 23981 | 0.020 |
Why?
|
Neoplasm Staging | 1 | 2024 | 11098 | 0.020 |
Why?
|
Referral and Consultation | 1 | 2021 | 3597 | 0.020 |
Why?
|
Colonic Neoplasms | 1 | 2018 | 2534 | 0.020 |
Why?
|
Adult | 4 | 2024 | 221122 | 0.020 |
Why?
|
Tuberculosis | 1 | 2018 | 2016 | 0.020 |
Why?
|
United States | 2 | 2024 | 72317 | 0.020 |
Why?
|
Massachusetts | 1 | 2018 | 8837 | 0.020 |
Why?
|
Medicare | 1 | 2022 | 6758 | 0.010 |
Why?
|
Communication | 1 | 2018 | 3870 | 0.010 |
Why?
|
Quality of Health Care | 1 | 2018 | 4330 | 0.010 |
Why?
|
Age Factors | 1 | 2019 | 18401 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2019 | 20092 | 0.010 |
Why?
|
Disease Progression | 1 | 2017 | 13500 | 0.010 |
Why?
|
Prospective Studies | 1 | 2021 | 54405 | 0.010 |
Why?
|
Postoperative Complications | 1 | 2017 | 15647 | 0.010 |
Why?
|
Aged, 80 and over | 1 | 2019 | 58946 | 0.010 |
Why?
|
Young Adult | 1 | 2019 | 59196 | 0.010 |
Why?
|